Pointer: Devina addresses considerations round US tariffs, notably on Indian pharma. She means that whereas Trump’s tariffs could have short-term results, India is much less impacted resulting from its smaller export share. She additionally underscores that geopolitical dangers, like Trump’s unpredictable actions, add uncertainty to the worldwide market.
